FDA also approved the FoundationOne Liquid CDx assay to be a companion diagnostic product to discover sufferers with breast cancer for therapy with inavolisib with palbociclib and fulvestrant. Prior to deciding to get Itovebi, tell your Health care supplier about your entire health care situation